Schizophrenia Trials in Oakland Park, United States
Conditions / Schizophrenia / Oakland Park, United States
Schizophrenia is a medical condition with active clinical research programs worldwide.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04624243 | Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008) | COMPLETED | — |
| NCT01432444 | Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole | COMPLETED | PHASE3 |
| NCT01716975 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT02694328 | A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) | COMPLETED | PHASE3 |
| NCT02717195 | Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia | COMPLETED | PHASE3 |
| NCT01903837 | A Study of ALKS 3831 in Adults With Schizophrenia | COMPLETED | PHASE2 |
| NCT01714713 | A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT02892422 | Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia | COMPLETED | PHASE3 |
| NCT05443724 | A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia | COMPLETED | PHASE2 |
| NCT02161718 | A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder | COMPLETED | PHASE2 |